Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)

被引:37
|
作者
Troeltzsch, Matthias [1 ,2 ]
Gogl, Markus [2 ]
Berndt, Ronald [3 ]
Troeltzsch, Markus [2 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Oral & Maxillofacial Surg & Facial Plast Sur, Lindwurmstr 2a, D-80337 Munich, Germany
[2] Ctr Oral Maxillofacial & Facial Reconstruct Surg, Ansbach, Germany
[3] Ansbach Gen Hosp, Dept Pathol, Ansbach, Germany
关键词
Ad26.COV2.S; COVID vaccine; COVID-19; oral lichen planus;
D O I
10.1111/odi.14025
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
引用
收藏
页码:2595 / 2596
页数:2
相关论文
共 50 条
  • [41] Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report
    Di Pietro, Martina
    Dono, Fedele
    Consoli, Stefano
    Evangelista, Giacomo
    Pozzilli, Valeria
    Calisi, Dario
    Barbone, Filomena
    Bonanni, Laura
    Onofrj, Marco
    De Angelis, Maria Vittoria
    Sensi, Stefano L.
    NEUROLOGICAL SCIENCES, 2022, 43 (05) : 2951 - 2956
  • [42] Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective
    Li, Nan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (03) : 360 - 362
  • [43] Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report
    Martina Di Pietro
    Fedele Dono
    Stefano Consoli
    Giacomo Evangelista
    Valeria Pozzilli
    Dario Calisi
    Filomena Barbone
    Laura Bonanni
    Marco Onofrj
    Maria Vittoria De Angelis
    Stefano L. Sensi
    Neurological Sciences, 2022, 43 : 2951 - 2956
  • [44] Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report
    Naghashzadeh, Farah
    Shafaghi, Shadi
    Dorudinia, Atosa
    Naji, Seyed Alireza
    Marjani, Majid
    Amin, Ahmad
    Mohamadifar, Arezoo
    Noorali, Sima
    Kashani, Babak Sharif
    ESC HEART FAILURE, 2022, 9 (02): : 1483 - 1486
  • [45] Ad26 vaccine. COV2.S (Janssen) against Covid-19
    不详
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (175): : 326 - 327
  • [46] Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
    Sablerolles, Roos S. G.
    Rietdijk, Wim J. R.
    Goorhuis, Abraham
    Postma, Douwe F.
    Visser, Leo G.
    Geers, Daryl
    Schmitz, Katharina S.
    Garrido, Hannah M. Garcia
    Koopmans, Marion P. G.
    Dalm, Virgil A. S. H.
    Kootstra, Neeltje A.
    Huckriede, Anke L. W.
    Lafeber, Melvin
    van Baarle, Debbie
    GeurtsvanKessel, Corine H.
    de Vries, Rory D.
    van der Kuy, P. Hugo M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 951 - 963
  • [47] EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
    John, Binu V.
    Doshi, Akash
    Deng, Yangyang
    Mansour, Natalie
    Barritt, Alfred Sidney
    Moon, Andrew M.
    Ioannou, George N.
    Martin, Paul
    Chao, Hann-Hsiang
    Taddei, Tamar H.
    Kaplan, David E.
    Dahman, Bassam
    GASTROENTEROLOGY, 2022, 162 (07) : S1248 - S1248
  • [48] Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States
    Lewis, Nathaniel M.
    Self, Wesley H.
    Gaglani, Manjusha
    Ginde, Adit A.
    Douin, David J.
    Talbot, H. Keipp
    Casey, Jonathan D.
    Mohr, Nicholas M.
    Zepeski, Anne
    Ghamande, Shekhar A.
    McNeal, Tresa A.
    Shapiro, Nathan, I
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Shehu, Arber
    Prekker, Matthew E.
    Erickson, Heidi L.
    Gong, Michelle N.
    Mohamed, Amira
    Johnson, Nicholas J.
    Srinivasan, Vasisht
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Monto, Arnold S.
    Khan, Akram
    Busse, Laurence W.
    ten Lohuis, Caitlin C.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Gordon, Alexandra June
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Rivas, Carolina
    Babcock, Hilary M.
    Kwon, Jennie H.
    Exline, Matthew C.
    Lauring, Adam S.
    Halasa, Natasha
    Chappell, James D.
    Grijalva, Carlos G.
    Rice, Todd W.
    Rhoads, Jillian P.
    Jones, Ian D.
    Stubblefield, William B.
    Baughman, Adrienne
    Womack, Kelsey N.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S159 - S166
  • [49] Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
    Montefiori, David C.
    CELL REPORTS MEDICINE, 2022, 3 (03)
  • [50] Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
    Marcel Kemper
    Christoph Berssenbrügge
    Georg Lenz
    Rolf Michael Mesters
    Annals of Hematology, 2022, 101 : 927 - 928